BACKGROUND: Older people often take multiple medications. It is a policy priority to facilitate older people to stay at home longer. Three-quarters of nursing home placements in the US are preceded by a hospitalization. OBJECTIVE: To investigate the association between polypharmacy and medication regimen complexity with hospital discharge destination among older people. METHODS: This prospective cohort study comprised patients aged ≥70 years consecutively admitted to the Geriatric Evaluation and Management unit at a tertiary hospital in Adelaide, Australia, between October 2010 and December 2011. Medication regimen complexity at discharge was calculated using the 65-item validated Medication Regimen Complexity Index (MRCI). Unadjusted and adjusted relative risks (RRs) with 95 % confidence intervals (CIs) were calculated for medication-related factors associated with discharge directly to home versus non-community settings (rehabilitation, transition care, and residential aged care). RESULTS: From 163 eligible patients, 87 were discharged directly to home (mean age 84.6 years, standard deviation [SD] 6.9; mean MRCI 26.1, SD 9.7), while 76 were discharged to non-community settings (mean age 85.8 years, SD 5.8; mean MRCI 29.9, SD 13.2). After adjusting for age, sex, comorbidity, and activities of daily living, having a high medication regimen complexity (MRCI >35) was inversely associated with discharge directly to home (RR 0.39; 95 % CI 0.20-0.73), whereas polypharmacy (≥9 medications) was not significantly associated with discharge directly to home (RR 0.97; 95 % CI 0.53-1.58). CONCLUSION: Having high medication regimen complexity was inversely associated with discharge directly to home, while polypharmacy was not associated with discharge destination.
BACKGROUND: Older people often take multiple medications. It is a policy priority to facilitate older people to stay at home longer. Three-quarters of nursing home placements in the US are preceded by a hospitalization. OBJECTIVE: To investigate the association between polypharmacy and medication regimen complexity with hospital discharge destination among older people. METHODS: This prospective cohort study comprised patients aged ≥70 years consecutively admitted to the Geriatric Evaluation and Management unit at a tertiary hospital in Adelaide, Australia, between October 2010 and December 2011. Medication regimen complexity at discharge was calculated using the 65-item validated Medication Regimen Complexity Index (MRCI). Unadjusted and adjusted relative risks (RRs) with 95 % confidence intervals (CIs) were calculated for medication-related factors associated with discharge directly to home versus non-community settings (rehabilitation, transition care, and residential aged care). RESULTS: From 163 eligible patients, 87 were discharged directly to home (mean age 84.6 years, standard deviation [SD] 6.9; mean MRCI 26.1, SD 9.7), while 76 were discharged to non-community settings (mean age 85.8 years, SD 5.8; mean MRCI 29.9, SD 13.2). After adjusting for age, sex, comorbidity, and activities of daily living, having a high medication regimen complexity (MRCI >35) was inversely associated with discharge directly to home (RR 0.39; 95 % CI 0.20-0.73), whereas polypharmacy (≥9 medications) was not significantly associated with discharge directly to home (RR 0.97; 95 % CI 0.53-1.58). CONCLUSION: Having high medication regimen complexity was inversely associated with discharge directly to home, while polypharmacy was not associated with discharge destination.
Authors: Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur Journal: J Clin Epidemiol Date: 2012-06-27 Impact factor: 6.437
Authors: Barbara Caecilia Wimmer; Kristina Johnell; Johan Fastbom; Michael David Wiese; J Simon Bell Journal: Eur J Clin Pharmacol Date: 2015-06-14 Impact factor: 2.953
Authors: Samanta Lalic; Kris M Jamsen; Barbara C Wimmer; Edwin C K Tan; Sarah N Hilmer; Leonie Robson; Tina Emery; J Simon Bell Journal: Eur J Clin Pharmacol Date: 2016-06-02 Impact factor: 2.953
Authors: Barbara C Wimmer; J Simon Bell; Johan Fastbom; Michael D Wiese; Kristina Johnell Journal: Ann Pharmacother Date: 2015-12-17 Impact factor: 3.154
Authors: Vanessa Alves-Conceição; Daniel Tenório da Silva; Vanessa Lima de Santana; Edileide Guimarães Dos Santos; Lincoln Marques Cavalcante Santos; Divaldo Pereira de Lyra Journal: BMC Pharmacol Toxicol Date: 2017-07-25 Impact factor: 2.483
Authors: Esa Yh Chen; Janet K Sluggett; Jenni Ilomäki; Sarah N Hilmer; Megan Corlis; Leonie J Picton; Laura Dean; Christopher P Alderman; Nicholas Farinola; Joy Gailer; Jane Grigson; Andrew R Kellie; Peter Jc Putsey; Solomon Yu; J Simon Bell Journal: Clin Interv Aging Date: 2018-05-18 Impact factor: 4.458
Authors: Jungwon Cho; Sangmi Shin; Young Mi Jeong; Eunsook Lee; Euni Lee Journal: Int J Environ Res Public Health Date: 2021-04-13 Impact factor: 3.390
Authors: Filipa Pereira; Henk Verloo; Armin von Gunten; María Del Río Carral; Carla Meyer-Massetti; Maria Manuela Martins; Boris Wernli Journal: BMJ Open Date: 2022-03-04 Impact factor: 2.692
Authors: Barbara Caecilia Wimmer; J Simon Bell; Johan Fastbom; Michael David Wiese; Kristina Johnell Journal: J Gerontol A Biol Sci Med Sci Date: 2015-12-26 Impact factor: 6.053